FDA Warning Issued for Pain Drug Fentora

Joe Saunders
Attorney
(866) 735-1102 Ext 340
Visit Joe Saunders on Avvo
Posted by Joe SaundersSeptember 27, 2007 10:45 AM

Fentora, used to treat pain in cancer patients, has drawn an FDA warning as a result of deaths in patients who were given the improper dosage or Fentora was incorrectly substituted as a pain management pharmaceutical. The FDA warning stated that Fentora should not be used in cancer patients who are unable to tolerate other opioid
drugs. Fentora was approved by the FDA last year for cancer patients to treat severe pain and who were already taking morphine or other fentanyl drugs.

For more information on this subject, please review our section on Drugs, Medical Devices, and Implants.

0 Comments

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

Comments for this article are closed.

Subscribe to InjuryBoard Sarasota

InjuryBoard Sarasota RSS Feeds

Keep up with the latest updates using your favorite RSS reader

Injury Board Sarasota is brought to you by Saunders and Walker

Legal Assistance Center

More Info
Saunders and Walker (866) 735-1102 Ext 340 www.saunderslawyers.com
google
Personal Injury Lawyers Serving: St. Petersburg, Tampa, Sarasota, Bradenton, Manatee, Largo, Palm Harbor, Pinellas Park, Tarpon Springs, Clearwater, Palmetto, Ellenton, Lakewood Ranch, Cortez, Anna Maria, Holmes Beach, Longboat Key
3491 Gandy BlvdSuite 200, Pinellas Park, Florida 33781 [ Show Map ]1001 3rd Ave W, Bradenton, Florida 34205 [ Show Map ]
Better Business Bureau Accredited Business Confidential

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address